Incidence of Ocular Manifestation After Adult-Onset Inflammatory Bowel Disease: A 20-Year Population-Based Cohort Study
Inflammatory Bowel Diseases · 2026
DOI: 10.1093/ibd/izaf213 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Inflammatory Bowel Diseases, 2026. Verfasst von Henit Yanai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, IBD Center, Rabin Medical Center, Petah Tikva, Israel. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Crohn Disease, Inflammatory Bowel Diseases, Scleritis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 13 Literaturangaben.
Abstract (Originalsprache)
Background
Ocular manifestations (OMs) are recognized extraintestinal complications in inflammatory bowel disease (IBD), but their incidence remains understudied. We aimed to evaluate the incidence and trends of OM in a large population-based cohort of adults with newly diagnosed IBD over the past 2 decades.
Methods
We conducted a retrospective cohort study including all adult-onset IBD patients between 2005 and 2024 in a large health maintenance organization. Patients with pre-existing OM diagnoses were excluded. The primary outcome was incident OM (uveitis, episcleritis/scleritis, or orbital inflammation) after IBD diagnosis. Annual incidence trends were assessed using the Cochran-Armitage test. Risk factors were analyzed via multivariable Cox regression, stratified by IBD type.
Results
Among 15 035 newly diagnosed IBD patients (51.8% Crohn’s disease [CD], 48.2% ulcerative colitis [UC]), 349 developed an OM over 119 669 person-years (incidence: 2.9 per 1000 person-years; 95% confidence interval [CI], 2.62-3.24). OM incidence was higher in CD than UC (log-rank P < .001) and remained stable over time (P = .125). The median time to OM was 45 months. In CD, female sex (hazard ratio [HR], 1.62; 95% CI, 1.24-2.13) and systemic corticosteroid use (HR, 1.62; 95% CI, 1.18-2.22) were significant risk factors. In UC, corticosteroids (HR, 2.17; 95% CI, 1.40-3.37) and intestinal surgery (HR, 3.50; 95% CI, 1.69-7.28) were associated with increased OM risk.
Conclusion
OMs in adult-onset IBD are infrequent but clinically relevant, particularly among CD patients and those with markers of severe disease. Clinician awareness and early referral remain essential for prompt diagnosis and management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Gastroenterology, IBD Center, Rabin Medical Center, Petah Tikva, Israel.
- Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
- Maccabi Healthcare Services, Tel Aviv, Israel.
- Arison School of Business, Reichman University, Herzliya, Israel.
- Institute of Pediatric Gastroenterology, Hepatology and Nutrition, Kaplan Medical Center, Rehovot, Israel.
- Hebrew University of Jerusalem, Jerusalem, Israel.
ORCID-Profile: Henit Yanai, Tali Sharar Fischler, Amit Assa
Zitieren
APA
Yanai, H., Achler, T., Ben-Tov, A., Sharar Fischler, T., Patalon, T., Gazit, S., Assa, A., & Shulman, S. (2026). Incidence of Ocular Manifestation After Adult-Onset Inflammatory Bowel Disease: A 20-Year Population-Based Cohort Study. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izaf213
Vancouver
Yanai H, Achler T, Ben-Tov A, Sharar Fischler T, Patalon T, Gazit S, et al. Incidence of Ocular Manifestation After Adult-Onset Inflammatory Bowel Disease: A 20-Year Population-Based Cohort Study. Inflammatory Bowel Diseases. 2026. doi:10.1093/ibd/izaf213
BibTeX
@article{Yanai2026,
author = {Yanai, Henit and Achler, Tomer and Ben-Tov, Amir and Sharar Fischler, Tali and Patalon, Tal and Gazit, Sivan and Assa, Amit and Shulman, Shiri},
title = {Incidence of Ocular Manifestation After Adult-Onset Inflammatory Bowel Disease: A 20-Year Population-Based Cohort Study},
journal = {Inflammatory Bowel Diseases},
year = {2026},
doi = {10.1093/ibd/izaf213}
}
EUVIMED